Cargando…

Tissue Transglutaminase Appears in Monocytes and Macrophages but Not in Lymphocytes in White Matter Multiple Sclerosis Lesions

Leukocyte infiltration is an important pathological hallmark of multiple sclerosis (MS) and is therefore targeted by current MS therapies. The enzyme tissue transglutaminase (TG2) contributes to monocyte/macrophage migration and is present in MS lesions and could be a potential therapeutic target. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chrobok, Navina L, Bol, John G J M, Wilhelmus, Micha M M, Drukarch, Benjamin, van Dam, Anne-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524631/ https://www.ncbi.nlm.nih.gov/pubmed/31058279 http://dx.doi.org/10.1093/jnen/nlz030

Ejemplares similares

Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
por: Chrobok, Navina L., et al.
Publicado: (2016)

Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis
por: Chrobok, Navina L., et al.
Publicado: (2018)

Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1(gfp/gfp) mice
por: Chrobok, Navina L., et al.
Publicado: (2016)

Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis
por: Chrobok, Navina L., et al.
Publicado: (2018)

Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2014)

Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?
por: Sestito, Claudia, et al.
Publicado: (2017)

Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis
por: Sestito, Claudia, et al.
Publicado: (2021)

Differential Expression of Tissue Transglutaminase Splice Variants in Peripheral Blood Mononuclear Cells of Primary Progressive Multiple Sclerosis Patients
por: Sestito, Claudia, et al.
Publicado: (2018)

Absence of tissue transglutaminase reduces amyloid‐beta pathology in APP23 mice
por: Wilhelmus, Micha M. M., et al.
Publicado: (2022)

Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis
por: Prins, Marloes, et al.
Publicado: (2013)

Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer’s disease mouse models
por: Wilhelmus, Micha M. M., et al.
Publicado: (2016)

The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease
por: Wilhelmus, Micha M. M., et al.
Publicado: (2022)

In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model
por: van der Wildt, Berend, et al.
Publicado: (2018)

Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients
por: Prins, Marloes, et al.
Publicado: (2014)

Brain macrophages acquire distinct transcriptomes in multiple sclerosis lesions and normal appearing white matter
por: Miedema, Anneke, et al.
Publicado: (2022)

Transglutaminases in Monocytes and Macrophages
por: Sun, Huifang, et al.
Publicado: (2018)

Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures
por: Espitia Pinzón, Nathaly, et al.
Publicado: (2017)

Thinking about the action potential: the nerve signal as a window to the physical principles guiding neuronal excitability
por: Drukarch, Benjamin, et al.
Publicado: (2023)

Tissue Transglutaminase Promotes Early Differentiation of Oligodendrocyte Progenitor Cells
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2019)

Abnormalities in normal-appearing white matter from which multiple sclerosis lesions arise
por: Elliott, Colm, et al.
Publicado: (2021)

Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2017)

Astrocyte-Derived Tissue Transglutaminase Interacts with Fibronectin: A Role in Astrocyte Adhesion and Migration?
por: van Strien, Miriam E., et al.
Publicado: (2011)

Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosis
por: Ahmed, Shanzeh M., et al.
Publicado: (2022)

Reduced Creatine Kinase B Activity in Multiple Sclerosis Normal Appearing White Matter
por: Steen, Christel, et al.
Publicado: (2010)

Diffusion-derived parameters in lesions, peri-lesion and normal-appearing white matter in multiple sclerosis using tensor, kurtosis and fixel-based analysis
por: van der Weijden, Chris WJ, et al.
Publicado: (2022)

White matter hyperintensities and normal-appearing white matter integrity in the aging brain
por: Maniega, Susana Muñoz, et al.
Publicado: (2015)

Mapping the relationship of white matter lesions to depression in multiple sclerosis
por: Baller, Erica B., et al.
Publicado: (2023)

Pathological ultrastructural alterations of myelinated axons in normal appearing white matter in progressive multiple sclerosis
por: Oost, Wendy, et al.
Publicado: (2023)

Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients
por: Bester, Maxim, et al.
Publicado: (2015)

Vasomotor reactivity comparison in multiple sclerosis patients with white matter lesions and nonmultiple sclerosis subjects with white matter lesions in brain magnetic resonance imaging
por: Khorvash, Fariborz, et al.
Publicado: (2016)

Increased HLA-E expression in white matter lesions in multiple sclerosis
por: Durrenberger, Pascal F, et al.
Publicado: (2012)

Longitudinal analysis of white matter and cortical lesions in multiple sclerosis
por: Fartaria, Mário João, et al.
Publicado: (2019)

A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis
por: Wheeler, David, et al.
Publicado: (2008)

Blood-Brain Barrier Permeability of Normal Appearing White Matter in Relapsing-Remitting Multiple Sclerosis
por: Lund, Henrik, et al.
Publicado: (2013)

Normal Appearing and Diffusely Abnormal White Matter in Patients with Multiple Sclerosis Assessed with Quantitative MR
por: West, Janne, et al.
Publicado: (2014)

Correction: Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients
por: Bester, Maxim, et al.
Publicado: (2015)

DNA methylation changes in glial cells of the normal-appearing white matter in Multiple Sclerosis patients
por: Kular, Lara, et al.
Publicado: (2022)

Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients
por: van Nierop, Gijsbert P., et al.
Publicado: (2017)

Lipidomic UPLC-MS/MS Profiles of Normal-Appearing White Matter Differentiate Primary and Secondary Progressive Multiple Sclerosis
por: Pousinis, Petros, et al.
Publicado: (2020)

Correlation between white matter damage and gray matter lesions in multiple sclerosis patients
por: Han, Xue-mei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1nljlnbpm89j4cldjejr8026o4